Drug Shortage Report for PMS-ABACAVIR-LAMIVUDINE
Report ID | 77526 |
Drug Identification Number | 02458381 |
Brand name | PMS-ABACAVIR-LAMIVUDINE |
Common or Proper name | ABACAVIR/LAMIVUDINE |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | ABACAVIR LAMIVUDINE |
Strength(s) | 600MG 300MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 |
ATC code | J05AR |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Shortage of an inactive ingredient or component. |
Anticipated start date | |
Actual start date | 2019-03-01 |
Estimated end date | 2022-04-25 |
Actual end date | 2022-06-22 |
Shortage status | Resolved |
Updated date | 2022-06-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v19 | 2022-06-23 | French | Compare |
v18 | 2022-06-23 | English | Compare |
v17 | 2021-11-17 | French | Compare |
v16 | 2021-11-17 | English | Compare |
v15 | 2021-06-18 | French | Compare |
v14 | 2021-06-18 | English | Compare |
v13 | 2021-06-18 | English | Compare |
v12 | 2020-07-07 | French | Compare |
v11 | 2020-07-07 | English | Compare |
v10 | 2020-03-10 | French | Compare |
v9 | 2020-03-10 | English | Compare |
v8 | 2019-12-24 | French | Compare |
v7 | 2019-12-24 | English | Compare |
v6 | 2019-09-12 | French | Compare |
v5 | 2019-09-12 | English | Compare |
v4 | 2019-05-09 | French | Compare |
v3 | 2019-05-09 | English | Compare |
v2 | 2019-03-04 | French | Compare |
v1 | 2019-03-04 | English | Compare |
Showing 1 to 19 of 19